{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:47:19Z","timestamp":1782877639795,"version":"3.54.5"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["ID1092262"],"award-info":[{"award-number":["ID1092262"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"A2 Milk Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The sudden arrival of the COVID-19 pandemic placed significant stresses on supply chains including viral transport medium (VTM). The VTM that was urgently required needed to support viral replication, as well as other routine diagnostic approaches. We describe the preparation and validation testing of VTM for rapidly expanding diagnostic testing, where the capacity of the VTM to preserve viral integrity, for culture, isolation and full sequence analysis, was maintained.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>VTM was prepared using different methods of sterilization then \u2018spiked\u2019 with virus. The VTM was investigated using viral culture in Vero cells, and for nucleic acid detection by quantitative PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The best results were obtained by filter and autoclave-based sterilization. The VTM proved robust for culture-based analyses provided the inoculated VTM was stored at 4\u00a0\u00b0C, and tested within 48\u00a0h. The filtered VTM also supported PCR-based diagnosis for at least 5\u00a0days when the mock inoculated VTM was held at room temperature.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>The manual handling of VTM production, including filling and sterilization, was optimized. SARS-CoV-2 was spiked into VTM to assess different sterilization methods and measure the effects of storage time and temperature upon VTM performance. While most diagnostic protocols will not require replication competent virus, the use of high quality VTM will allow for the next phase of laboratory analysis in the COVID-19 pandemic, including drug and antibody susceptibility analysis of re-isolated SARS-CoV-2, and for the testing of vaccine escape mutants.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12985-021-01525-z","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T08:03:30Z","timestamp":1615363410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Optimal preparation of SARS-CoV-2 viral transport medium for culture"],"prefix":"10.1186","volume":"18","author":[{"given":"Julie","family":"McAuley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Paraskeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Trajcevska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sait","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Bert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Purcell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0614-5641","authenticated-orcid":false,"given":"Richard","family":"Strugnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"1525_CR1","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1128\/JCM.06551-11","volume":"50","author":"J Druce","year":"2012","unstructured":"Druce J, Garcia K, Tran T, Papadakis G, Birch C. Evaluation of swabs, transport media, and specimen transport conditions for optimal detection of viruses by PCR. J Clin Microbiol. 2012;50:1064\u20135.","journal-title":"J Clin Microbiol"},{"key":"1525_CR2","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.50726","author":"E Williams","year":"2020","unstructured":"Williams E, Bond K, Isles N, Chong B, Johnson D, Druce J, Hoang T, Ballard SA, Hall V, Muhi S, Buising KL, Lim S, Strugnell D, Catton M, Irving LB, Howden BP, Bert E, Williamson DA. Pandemic printing: a novel 3D-printed swab for detecting SARS-CoV-2. Med J Aust. 2020. https:\/\/doi.org\/10.5694\/mja2.50726.","journal-title":"Med J Aust"},{"key":"1525_CR3","doi-asserted-by":"publisher","first-page":"459","DOI":"10.5694\/mja2.50569","volume":"212","author":"L Caly","year":"2020","unstructured":"Caly L, Druce J, Roberts J, Bond K, Tran T, Kostecki R, Yoga Y, Naughton W, Taiaroa G, Seemann T, Schultz MB, Howden BP, Korman TM, Lewin SR, Williamson DA, Catton MG. Isolation and rapid sharing of the 2019 novel coronavirus (SARS-CoV-2) from the first patient diagnosed with COVID-19 in Australia. Med J Aust. 2020;212:459\u201362.","journal-title":"Med J Aust"},{"key":"1525_CR4","doi-asserted-by":"publisher","DOI":"10.1099\/jmm.0.001238","author":"JYH Lee","year":"2020","unstructured":"Lee JYH, Best N, McAuley J, Porter JL, Seemann T, Schultz MB, Sait M, Orlando N, Mercoulia K, Ballard SA, Druce J, Tran T, Catton MG, Pryor MJ, Cui HL, Luttick A, McDonald S, Greenhalgh A, Kwong JC, Sherry NL, Graham M, Hoang T, Herisse M, Pidot SJ, Williamson DA, Howden BP, Monk IR, Stinear TP. Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA. J Med Microbiol. 2020. https:\/\/doi.org\/10.1099\/jmm.0.001238.","journal-title":"J Med Microbiol"},{"key":"1525_CR5","doi-asserted-by":"crossref","unstructured":"Reed LJ, Muench H. 1938. A simple method of estimating fifty per cent endpoints. American Journal of Hygeine 27.","DOI":"10.1093\/oxfordjournals.aje.a118408"},{"key":"1525_CR6","doi-asserted-by":"crossref","unstructured":"Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, Bleicker T, Brunink S, Schneider J, Schmidt ML, Mulders DG, Haagmans BL, van der Veer B, van den Brink S, Wijsman L, Goderski G, Romette JL, Ellis J, Zambon M, Peiris M, Goossens H, Reusken C, Koopmans MP, Drosten C. 2020. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Euro Surveill 25.","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"1525_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.disamonth.2020.101067:101067","author":"DRB McFee","year":"2020","unstructured":"McFee DRB. COVID-19: TESTING - Laboratory Testing - CDC Guidelines. Dis Mon. 2020. https:\/\/doi.org\/10.1016\/j.disamonth.2020.101067:101067.","journal-title":"Dis Mon"},{"key":"1525_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.jmoldx.2020.04.209","volume":"22","author":"J Radbel","year":"2020","unstructured":"Radbel J, Jagpal S, Roy J, Brooks A, Tischfield J, Sheldon M, Bixby C, Witt D, Gennaro ML, Horton DB, Barrett ES, Carson JL, Panettieri RA Jr, Blaser MJ. Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Is comparable in clinical samples preserved in saline or viral transport medium. J Mol Diagn. 2020;22:871\u20135.","journal-title":"J Mol Diagn"},{"key":"1525_CR9","doi-asserted-by":"publisher","first-page":"113947","DOI":"10.1016\/j.jviromet.2020.113947","volume":"285","author":"L Garnett","year":"2020","unstructured":"Garnett L, Bello A, Tran KN, Audet J, Leung A, Schiffman Z, Griffin BD, Tailor N, Kobasa D, Strong JE. Comparison analysis of different swabs and transport mediums suitable for SARS-CoV-2 testing following shortages. J Virol Methods. 2020;285:113947.","journal-title":"J Virol Methods"},{"key":"1525_CR10","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1139\/y00-075","volume":"79","author":"A Chapelier","year":"2001","unstructured":"Chapelier A, Desmadril M, Houee-Levin C. Gamma radiation effects on alpha-lactalbumin: structural modifications. Can J Physiol Pharmacol. 2001;79:154\u20137.","journal-title":"Can J Physiol Pharmacol"},{"key":"1525_CR11","doi-asserted-by":"publisher","unstructured":"Zeng C, Evans JP, Pearson R, Qu P, Zheng YM, Robinson RT, Hall-Stoodley L, Yount J, Pannu S, Mallampalli RK, Saif L, Oltz E, Lozanski G, Liu SL. 2020. Neutralizing antibody against SARS-CoV-2 spike in COVID-19 patients, health care workers and convalescent plasma donors: a cohort study using a rapid and sensitive high-throughput neutralization assay. medRxiv doi:https:\/\/doi.org\/10.1101\/2020.08.02.20166819.","DOI":"10.1101\/2020.08.02.20166819"},{"key":"1525_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-020-00431-9","author":"DB Matthews","year":"2020","unstructured":"Matthews DB. A cocktail of antibodies for COVID-19 therapy. Nat Rev Immunol. 2020. https:\/\/doi.org\/10.1038\/s41577-020-00431-9.","journal-title":"Nat Rev Immunol"},{"key":"1525_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","volume":"583","author":"D Pinto","year":"2020","unstructured":"Pinto D, Park YJ, Beltramello M, Walls AC, Tortorici MA, Bianchi S, Jaconi S, Culap K, Zatta F, De Marco A, Peter A, Guarino B, Spreafico R, Cameroni E, Case JB, Chen RE, Havenar-Daughton C, Snell G, Telenti A, Virgin HW, Lanzavecchia A, Diamond MS, Fink K, Veesler D, Corti D. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature. 2020;583:290\u20135.","journal-title":"Nature"},{"key":"1525_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2020.198114:198114","author":"SP Kaur","year":"2020","unstructured":"Kaur SP, Gupta V. COVID-19 Vaccine: a comprehensive status report. Virus Res. 2020. https:\/\/doi.org\/10.1016\/j.virusres.2020.198114:198114.","journal-title":"Virus Res"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12985-021-01525-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-021-01525-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T08:14:29Z","timestamp":1615364069000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-021-01525-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1525"],"URL":"https:\/\/doi.org\/10.1186\/s12985-021-01525-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-127019\/v1","asserted-by":"object"}]},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"9 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethics approvals were necessary for this work. Studies conducted under highly containment, i.e. the PC3 Laboratory of the Peter Doherty Institute, were per protocol, where all investigators were trained by accredited trainers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All the authors consent to the publication of the manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"There are no competing financial interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"53"}}